Pat  Beyer net worth and biography

Pat Beyer Biography and Net Worth

Insider of CONMED
PATRICK J. BEYER joined the Company as President of CONMED International in December 2014. Prior to joining the Company, Mr. Beyer served as Chief Executive Officer of ICNet, a privately held infectious control software company from 2010 to 2014 when the company was sold. Prior to this, Mr. Beyer spent 21 years at Stryker Corporation where he led Stryker Europe from 2005-2009; Stryker UK, South Africa and Ireland from 2002 to 2005 and Stryker Medical from 1999 to 2002. Mr. Beyer graduated from Kalamazoo College with a BA in Economics, Western Michigan University with an MBA in Finance and Harvard Business School’s Advanced Management Program.

What is Pat Beyer's net worth?

The estimated net worth of Pat Beyer is at least $763,946.83 as of April 30th, 2024. Mr. Beyer owns 10,807 shares of CONMED stock worth more than $763,947 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Beyer may own. Additionally, Mr. Beyer receives a salary of $1,600,000.00 as Insider at CONMED. Learn More about Pat Beyer's net worth.

How old is Pat Beyer?

Mr. Beyer is currently 58 years old. There are 8 older executives and no younger executives at CONMED. The oldest executive at CONMED is Mr. David R. Murray, President of ConMed Electrosurgery, who is 76 years old. Learn More on Pat Beyer's age.

What is Pat Beyer's salary?

As the Insider of CONMED Co., Mr. Beyer earns $1,600,000.00 per year. The highest earning executive at CONMED is Mr. Curt R. Hartman, Chairman of the Board, CEO & President, who commands a salary of $2,450,000.00 per year. Learn More on Pat Beyer's salary.

How do I contact Pat Beyer?

The corporate mailing address for Mr. Beyer and other CONMED executives is 525 FRENCH ROAD, UTICA NY, 13502. CONMED can also be reached via phone at (727) 392-6464. Learn More on Pat Beyer's contact information.

Has Pat Beyer been buying or selling shares of CONMED?

Pat Beyer has not been actively trading shares of CONMED in the last ninety days. Most recently, on Tuesday, April 30th, Pat Beyer bought 3,000 shares of CONMED stock. The stock was acquired at an average cost of $68.30 per share, with a total value of $204,900.00. Following the completion of the transaction, the chief operating officer now directly owns 10,807 shares of the company's stock, valued at $738,118.10. Learn More on Pat Beyer's trading history.

Who are CONMED's active insiders?

CONMED's insider roster includes Pat Beyer (Insider), Brian Concannon (Director), Todd Garner (CFO), Curt Hartman (Chairman of the Board, CEO & President), Daniel Jonas (Insider), John Kennedy (EVP), Stanley Peters, III (VP), Peter Shagory (EVP), and Mark Tryniski (Director). Learn More on CONMED's active insiders.

Are insiders buying or selling shares of CONMED?

In the last twelve months, CONMED insiders bought shares 3 times. They purchased a total of 6,442 shares worth more than $446,732.92. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 6,300 shares worth more than $540,119.00. The most recent insider tranaction occured on June, 14th when insider Stanley W Peters III sold 4,000 shares worth more than $287,280.00. Insiders at CONMED own 6.8% of the company. Learn More about insider trades at CONMED.

Information on this page was last updated on 6/14/2024.

Pat Beyer Insider Trading History at CONMED

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2024Buy3,000$68.30$204,900.0010,807View SEC Filing Icon  
See Full Table

Pat Beyer Buying and Selling Activity at CONMED

This chart shows Pat Beyer's buying and selling at CONMED by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CONMED Company Overview

CONMED logo
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Read More

Today's Range

Now: $70.69
Low: $70.27
High: $72.10

50 Day Range

MA: $69.64
Low: $61.80
High: $76.93

2 Week Range

Now: $70.69
Low: $61.05
High: $117.27

Volume

262,558 shs

Average Volume

487,489 shs

Market Capitalization

$2.18 billion

P/E Ratio

16.79

Dividend Yield

1.11%

Beta

1.45